ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2035

$1.52M Total Retail Price of All Prescriptions

Rank: 15 out of 2035

877 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 877 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

42% of this provider’s 877 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 13,288 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,773 507 S3 1 2
OMEPRAZOLE 845 448 2 5
LEVOTHYROXINE SODIUM 690 447 3 4
LISINOPRIL 648 433 4 3
METOPROLOL TARTRATE 621 386 5 8
SIMVASTATIN 620 397 6 1
AMLODIPINE BESYLATE 515 331 7 6
FUROSEMIDE 500 290 8 7
OXYCODONE HCL 442 66 S2 9 62
SERTRALINE HCL 420 256 10 23
CARISOPRODOL 420 32 R 10 57
METFORMIN HCL 402 209 12 9
GABAPENTIN 399 144 13 14
WARFARIN SODIUM 352 251 14 11
POLYETHYLENE GLYCOL 3350 318 200 15 48
LOVASTATIN 304 132 16 33
CITALOPRAM HBR 295 115 17 20
NAMENDA 295 270 17 37
HYDROCHLOROTHIAZIDE 289 121 19 12
TRAMADOL HCL 285 175 20 19
BUMETANIDE 279 175 21 79
QUETIAPINE FUMARATE 268 182 22 70
PROAIR HFA 256 46 23 31
METHADONE HCL 254 43 S2 24 93
IBUPROFEN 231 66 25 43
ATORVASTATIN CALCIUM 230 164 26 13
AZITHROMYCIN 227 81 27 39
MIRTAZAPINE 218 159 28 46
SPIRIVA 206 111 29 44
ZOLPIDEM TARTRATE 205 69 30 21
POTASSIUM CHLORIDE 204 134 31 18
DIVALPROEX SODIUM 204 112 31 75
DONEPEZIL HCL 202 182 33 24
GLYBURIDE 197 137 R 34 74
ATENOLOL 196 151 35 10
TRAZODONE HCL 192 64 36 50
RISPERIDONE 184 91 37 68
LANTUS 176 96 38 40
SPIRONOLACTONE 174 97 39 65
TAMSULOSIN HCL 173 146 40 25
OXYCODONE HCL-ACETAMINOPHEN 171 34 S2 41 127
NEXIUM 168 62 42 51
ADVAIR DISKUS 167 107 43 38
CYCLOBENZAPRINE HCL 163 40 R 44 64
FENTANYL 161 57 S2 45 53
NAPROXEN 158 93 46 92
OXYCODONE-ACETAMINOPHEN 153 54 S2 47 181
CARVEDILOL 143 84 48 22
LEVETIRACETAM 134 48 49 87
NOVOLOG 134 58 49 95
LOSARTAN-HYDROCHLOROTHIAZIDE 132 60 51 47
RANITIDINE HCL 130 46 52 28
VENTOLIN HFA 122 36 53 80
CEPHALEXIN 121 46 54 91
ALLOPURINOL 118 72 55 34
ALENDRONATE SODIUM 116 96 56 27
TOPIRAMATE 111 11 57 184
KLOR-CON M20 111 65 57 73
PROMETHAZINE HCL 110 42 R 59 106
CIPROFLOXACIN HCL 110 69 59 63
FINASTERIDE 110 108 59 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 41 62 26
SYMBICORT 105 49 63 107
DIGOXIN 104 64 64 67
NOVOLIN 70-30 104 66 64 178
HYDRALAZINE HCL 99 69 66 45
LIDODERM 98 34 67 72
SEROQUEL 98 53 67 153
TRIAMCINOLONE ACETONIDE 98 38 67 142
OLANZAPINE 97 69 70 121
MORPHINE SULFATE ER 95 23 S2 71 86
ACETAMINOPHEN-CODEINE 95 56 S3 71 52
MELOXICAM 94 45 73 56
ISOSORBIDE MONONITRATE ER 94 83 73 32
OXYBUTYNIN CHLORIDE 93 44 75 102
NOVOLOG FLEXPEN 92 54 76 133
LYRICA 91 0 77 89
FLUTICASONE PROPIONATE 91 22 77 29
PEN NEEDLE 90 47 79 100
PREDNISONE 89 42 80 36
METHYLPREDNISOLONE 86 23 81 125
OXYBUTYNIN CHLORIDE ER 84 58 82 117
BACLOFEN 84 28 82 112
ESCITALOPRAM OXALATE 83 51 84 77
CLOPIDOGREL 82 54 85 30
CLONIDINE HCL 82 49 85 61
HUMULIN 70-30 81 45 87 343
PLAVIX 79 61 88 49
INSULIN SYRINGE 79 35 88 97
DIVALPROEX SODIUM ER 78 0 90 226
PANTOPRAZOLE SODIUM 78 30 90 42
PHENYTOIN SODIUM EXTENDED 78 15 90 132
PAROXETINE HCL 77 48 93 69
ALBUTEROL SULFATE 75 67 94 90
METOPROLOL SUCCINATE 74 45 95 16
NIFEDIPINE ER 74 42 95 98
LAMOTRIGINE 74 29 95 203
LOSARTAN POTASSIUM 74 46 95 15
BUPROPION HCL SR 71 34 99 202
CYMBALTA 70 52 100 59
VENLAFAXINE HCL 70 20 100 265
MECLIZINE HCL 69 39 102 147
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 31 103 110
ENULOSE 63 22 104 230
AMMONIUM LACTATE 63 45 104 155
LANTUS SOLOSTAR 62 28 106 66
PRAVASTATIN SODIUM 61 48 107 17
TRICOR 59 14 108 120
RENVELA 59 33 108 245
FENOFIBRATE 59 0 108 82
FLUOXETINE HCL 59 0 108 81
AMOXICILLIN 58 19 112 116
NOVOLIN R 58 16 112 210
MORPHINE SULFATE 58 34 S2 112 183
OXYCONTIN 57 0 S2 115 152
CLINDAMYCIN HCL 57 20 115 388
INDOMETHACIN 54 27 R 117 280
VERAPAMIL ER 54 24 117 115
HYDROXYZINE HCL 54 26 R 117 208
FLOVENT HFA 52 11 120 238
NITROSTAT 51 26 121 167
SUBOXONE 51 0 121 160
AMITRIPTYLINE HCL 51 0 R 121 101
LIPITOR 50 38 124 134
FAMOTIDINE 50 48 124 71
METOCLOPRAMIDE HCL 50 14 124 144
LEVOFLOXACIN 50 26 124 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.